| 17/04/2024 |
09:35 to 10:25 |
Golden Hall |
Prostate Module - Localized Prostate Cancer Session |
10:00 to 10:20 |
Intensification of radiotherapy treatment in localized prostate cancer |
Speaker |
| 17/04/2024 |
09:35 to 10:25 |
Golden Hall |
Prostate Module - Localized Prostate Cancer Session |
10:20 to 10:25 |
Discussion |
Discussant |
| 17/04/2024 |
10:25 to 10:55 |
Golden Hall |
Clinical cases: low and intermediate risk prostate cancer (session 1) |
|
|
Discussant |
| 17/04/2024 |
10:55 to 11:40 |
Golden Hall |
Prostate Module - Localized Prostate Cancer Session |
11:15 to 11:35 |
Evolution of RTOG and NRG studies in prostate cancer |
Speaker |
| 17/04/2024 |
10:55 to 11:40 |
Golden Hall |
Prostate Module - Localized Prostate Cancer Session |
11:35 to 11:40 |
Discussion |
Discussant |
| 17/04/2024 |
11:40 to 12:10 |
Golden Hall |
Clinical cases: low and intermediate risk prostate cancer (session 2) |
|
|
Discussant |
| 17/04/2024 |
14:50 to 15:30 |
Golden Hall |
Clinical cases: high-risk prostate cancer (session 1) |
|
|
Discussant |
| 18/04/2024 |
08:50 to 09:45 |
Golden Hall |
Clinical cases: recurrent prostate cancer |
|
|
Discussant |
| 18/04/2024 |
10:05 to 11:15 |
Golden Hall |
Prostate Module - Metastatic Disease Session |
10:25 to 10:45 |
The Role of External Radiation Therapy in Patients With Metastatic Prostate Cancer |
Speaker |
| 18/04/2024 |
10:05 to 11:15 |
Golden Hall |
Prostate Module - Metastatic Disease Session |
10:45 to 10:50 |
Discussion |
Discussant |
| 18/04/2024 |
11:15 to 11:55 |
Golden Hall |
Clinical cases: metastatic castration-sensitive prostate cancer |
|
|
Discussant |
| 19/04/2024 |
12:05 to 12:45 |
Golden Hall |
Clinical cases: bladder cancer - muscle-invasive disease |
|
|
Discussant |
